Pictet Asset Management (UK)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-274,900
| Closed | -$2.93M | – | 906 |
|
|
2015
Q1 | $2.93M | Sell |
274,900
-176,665
| -39% | -$1.88M | 0.01% | 689 |
|
|
2014
Q4 | $6.39M | Buy |
451,565
+243,765
| +117% | +$3.45M | 0.03% | 514 |
|
|
2014
Q3 | $2.86M | Sell |
207,800
-10,200
| -5% | -$140K | 0.01% | 676 |
|
|
2014
Q2 | $3.35M | Buy |
218,000
+33,100
| +18% | +$509K | 0.02% | 646 |
|
|
2014
Q1 | $3.15M | Buy |
184,900
+46,400
| +34% | +$791K | 0.02% | 650 |
|
|
2013
Q4 | $1.79M | Buy |
+138,500
| New | +$1.79M | 0.01% | 750 |
|